DOCSLIB.ORG

Investment Leading to Sustainable Growth

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Investment Leading to Sustainable Growth Corporate Information 048 Corporate Governance 058 History of the JT Group Japan Tobacco Inc. Annual Report FY2017 062 Regulation and Other Relevant Laws Year ended December 31, 2017 065 Litigation 066 Members of the Board, Audit Investment Operations & Analysis and Supervisory Board Members, leading and Executive Officers to sustainable 018 Industry Overview 067 Members of the JTI growth. 018 Tobacco Business Executive Committee 021 Pharmaceutical Business 067 Corporate Data 021 Processed Food Business 068 Investor Relations Activity 022 Review of Operations 069 Shareholder Information 022 International Tobacco Business 028 Japanese Domestic Tobacco Business 032 Global Tobacco Strategy 034 Pharmaceutical Business 038 Processed Food Business 040 Risk Factors Management 044 JT Group and Sustainability 046 Environmental, Social and 001 Performance Indicators Governance Initiatives 002 At a Glance 004 Consolidated Five-Year Financial Summary 006 Message from the Chairman and CEO Financial Information 008 CEO Business Review 010 Highlights (JT Group’s 2017) 071 Message from CFO 012 Management Principle, Strategic 072 Financial Review Framework and Resource Allocation 080 Consolidated Financial Statements 014 Business Plan 2018 086 Notes to Consolidated 015 Role and Target of Each Business Financial Statements 016 Performance Measures 139 Independent Auditor’s report 140 Glossary of Terms Management Performance Indicators Adjusted Operating Profit Dividend per Share 585.3 14 0 (JPY BN) (JPY) - 0.3% +7. 7 % Year-on-Year Change Year-on-Year Change - 0.6% Factsheets available at: Year-on-Year Change at Constant Exchange Rates https://www.jt.com/investors/results/annual_report/ Unless the context indicates otherwise, references in this Annual Report to ‘we’, ‘us’, In addition, these forward-looking statements are necessarily dependent upon ‘our’, ‘Japan Tobacco’, ‘JT Group’ or ‘JT’ are to Japan Tobacco Inc. and its consolidated assumptions, estimates and data that may be incorrect or imprecise and involve known subsidiaries. References to ‘JTI’ are to JTI Holding B.V., our consolidated subsidiary, and and unknown risks and uncertainties. Forward-looking statements regarding operating its consolidated subsidiaries. References to ‘TableMark’ are to TableMark Holdings Co., results are particularly subject to a variety of assumptions, some or all of which may not Ltd., TableMark Co., Ltd. and its Group companies. References to ‘Japan Tobacco Inc.’ be realized. are only to Japan Tobacco Inc. and references to ‘JT International Holding B.V.’ are only to JTI Holding B.V. References to ‘audit & supervisory board’ are to ‘kansayaku-kai’ Risks, uncertainties or other factors that could cause actual results to differ materially (as defined in the Companies Act of Japan) that performs certain supervisory functions from those expressed in any forward-looking statement include, without limitation: through its monitoring and audit activities within the overall scheme of corporate governance pursuant to the Companies Act of Japan. References to ‘audit & supervisory 1. change in consumer’s needs and preferences, and decrease in demand for tobacco board member’ are to a member or members of an audit & supervisory board, also products in key markets; referred to in Japanese as ‘kansayaku’ (as defined in the Companies Act of Japan). 2. restrictions on promoting, marketing, packaging, labeling and usage of tobacco products in markets in which we operate; Forward-looking statements 3. increases in excise, consumption or other taxes on tobacco products in markets This report contains forward-looking statements. These statements appear in a in which we operate; number of places in this report and include statements regarding the intent, belief, 4. litigation around the world alleging adverse health and financial effects resulting or current and future expectations of our management with respect to our business, from, or relating to, tobacco products; financial condition and results of operations. In some cases, you can identify 5. our ability to realize anticipated results of our acquisition or other similar forward-looking statements by terms such as ‘may’, ‘will’, ‘should’, ‘would’, ‘expect’, investments; ‘intend’, ‘project’, ‘plan’, ‘aim’, ‘seek’, ‘target’, ‘anticipate’, ‘believe’, ‘estimate’, ‘predict’, 6. competition in markets in which we operate or into which we seek to expand; ‘potential’ or the negative of these terms or other similar terminology. 7. deterioration in economic conditions in areas that matter to us; These statements are not guarantees of future performance and are subject to 8. economic, regulatory and political changes, such as nationalization, terrorism, various risks and uncertainties. Actual results, performance or achievements, or wars and civil unrest, in countries in which we operate; those of the industries in which we operate, may differ materially from any future 9. fluctuations in foreign exchange rates and the costs of raw materials; and results, performance or achievements expressed or implied by these 10. catastrophes, including natural disasters. forward-looking statements. 3 Japan Tobacco Inc. Annual Report 2017 Japan Tobacco Inc. Annual Report 2017 001 Management Performance Indicator 001 At a Glance 002 At a Glance Consolidated Five-Year Financial Summary 004 Message from the Chairman and CEO 006 CEO Business Review 008 2017 Highlights (JT Group’s) 010 Our Businesses Management Principle, Strategic FY2017: Results for the fiscal year ended December 31, 2017 Framework and Resource Allocation 012 Business Plan 2018 014 Role and Target of Each Business 015 Performance Measures 016 Our products are sold in over 130 countries and our Revenue breakdown by business segment The JT Group is a leading internationally recognized brands include Winston, Camel, MEVIUS and LD. Processed Food Others international tobacco We are also active in pharmaceutical and processed 7.6% 0.4% food businesses and we expect them to establish a foundation for continuous profit contribution, as Pharmaceutical International Tobacco company with operations we strive for sustainable growth. 4.9% 57.8% Japanese Domestic Tobacco in over 70 countries. 29.3% International Tobacco Business Japanese Domestic Tobacco Business Pharmaceutical Business Processed Food Business The international tobacco business is the JT Group’s We are the market leader in Japan, which is one of JT Group’s pharmaceutical business focuses on With Group company TableMark Co., Ltd. taking a growth engine, generating over 60% of the Group’s the largest markets in the world, generating about the research and development, production and sale central role, the processed food business is primarily consolidated adjusted operating profit. Looking 40% of our consolidated adjusted operating profit. of prescription pharmaceutical products. Its mission engaged in business concerning frozen and ambient ahead, we expect it will continue its strong contribution, We continue to be a significant profit contributor to is to build world-class, unique research and processed food, mainly staple food products such as strengthening competitiveness of the JT Group to the JT Group. development capabilities and reinforce its market frozen noodles, frozen rice, packed cooked rice and drive sustainable growth in the mid- to long-term. presence through innovative drugs. JT concentrates frozen baked bread, and seasoning including yeast During 2017, our SOM** reached 61.3%, thanks to the on research and development activities mainly extracts and oyster sauce. Our international brands portfolio is competitive and solid performance of our core brands, such as MEVIUS on the fields of metabolic diseases; viral infection; well-balanced, with strong equity brands across all and Natural American Spirit. Thus, we further solidified and autoimmune/inflammatory diseases, while We have solidified its No. 3 position in the frozen relevant product categories and price segments. our No. 1 position in cigarettes. In addition, we launched Torii Pharmaceutical Co., Ltd. is in charge of food industry with several top-selling products within The portfolio includes leading international brands Ploom shops and expanded the sales of Ploom TECH manufacturing as well as sales and promotion respective categories, such as frozen Udon noodles in cigarettes and fine cut, such as Winston, Mevius, in Tokyo. in the domestic market. and frozen Okonomiyaki. Camel and LD, as well as in Reduced-Risk Products (RRP)*, such as Ploom TECH and Logic. Results for FY2017: Results for FY2017: Earnings increased and achieved a record high profit. Achieved profit growth for the fifth consecutive year. Results for FY2017: Results for FY2017: Robust profit growth at constant exchange rates Adjusted operating profit decreased due to lower underpinned by resilient volume performance, cigarette sales volume partially offset by the positive Global Flagship Brands (GFB) momentum optimization of investments. Japan Tobacco around the World (Tobacco Business) and planned initiatives to optimize the manufacturing Composition of JT SOM** as of 2017 footprint and overall cost base. Sweden MEVIUS Germany Key Drivers: Winston • Positive GFB momentum driven by share gains Russia Seven Stars • Stronger business base from acquisitions Natural American Spirit Poland • Global supply chain optimization Belgium Pianissimo Canada Ukraine • Focused investments behind Switzerland Romania Peace Serbia Kazakhstan Japan – Global Flagship Brands, HOPE US Turkey Iran – Emerging
Load more

Recommended publications
  • Japan Tobacco to Take Over JTI (Malaysia)
    Volume 32 Strictly For Internal Use Only April 2014 ASEAN: Updates on OTP - Bans and Regulations While we have been focusing on cigarettes, but what about Other Tobacco Products (OTP)? Some examples of OTP are smokeless tobacco, roll-your-own and cigarillos. In the Philippines, the law requires health warning on OTP, which is considered similar to cigarettes; there is an advertising ban on OTP in mass media while advertising at POS is permitted. In Cambodia, OTP is covered under the Sub-Decree No. 35 on the Measures to Ban Advertising of Tobacco Products in 2011. In Thailand, the TC law states any tobacco product coming from Nicotiana Tabaccum needs to be treated as same as cigarette, and OTP is included. For Vietnam, OTP is banned as stated in Article 9, Vietnam Tobacco Law which strictly prohibited advertising and promotion of tobacco products. In Lao PDR, OTP is covered by TC law as same as all type of cigarettes but there is no tax charge for OTP. With strong regulation on cigarettes, people may switch to OTP. According to regulations on OTP, countries consider them as harmful products that need to be banned. However, information on OTP is still lacking and it could result in escaping enforcement. The MAC Network is not limited to cigarettes only but includes OTP. Please share more information on OTP on SIS MAC Network Facebook for effective counteraction against all tobacco products. Malaysia: Japan Tobacco to take over JTI (Malaysia) April 1, (Free Malaysia Today) JT International (Malaysia), which makes Camel and Salem cigarettes, has received a takeover offer of RM808.4 million from Japan Tobacco to buy the remaining 39.63% or 103.549 million shares.
    [Show full text]
  • 3.1 Measuring Tobacco Use Behaviours
    chap3.1janvier13:Layout 1 13/01/2009 09:55 Page 75 3.1 Measuring tobacco use behaviours Introduction semination of tobacco-related Natural history of tobacco use surveillance data.” The majority of tobacco control In addition, Section 1-d of Article The natural history of tobacco use is policies are designed to reduce 21 requires each ratifying nation to often conceptualized as a series of tobacco use or exposure to tobacco provide periodic updates on sur- steps that can progress from never smoke in the environment; stra- veillance and research as specified use, to trial, experimentation, estab- tegies that are clearly supported by in Article 20. Article 22 calls for lished use, attempting to quit, the scientific literature (US cooperation among the Parties to relapse, and/or maintenance of Department of Health and Human promote the transfer of technical cessation (Figure 3.1 and Table 3.1) Services, 2004, 2006; IARC, 2004, and scientific expertise on sur- (US Department of Health and 2007a). Preventing initiation and veillance and evaluation, among Human Services, 1990, 1994; promoting quitting are the two major other topics (WHO, 2003). Marcus et al. , 1993; Pierce et al ., tobacco control strategies designed This section will first review the 1998b; Mayhew et al., 2000; Choi et to reduce use. To facilitate pro- natural history of tobacco use (e.g. al. , 2001; Hughes et al ., 2003). Prior gress, article 20 of the WHO initiation, current use, cessation). In to actual initiation of use, never Framework Convention on Tobacco epidemiologic studies of disease users often think about use, a step Control (FCTC) calls for Parties to: etiology, such as those discussed in in the process that is described in IARC Monographs (e.g.
    [Show full text]
  • Tobacco Use Disorder and Treatment: New Challenges and Opportunities
    University of Massachusetts Medical School eScholarship@UMMS Open Access Articles Open Access Publications by UMMS Authors 2017-09-01 Tobacco use disorder and treatment: new challenges and opportunities Douglas Ziedonis University of California - San Diego Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/oapubs Part of the Behavior and Behavior Mechanisms Commons, Neuroscience and Neurobiology Commons, and the Substance Abuse and Addiction Commons Repository Citation Ziedonis D, Das S, Larkin C. (2017). Tobacco use disorder and treatment: new challenges and opportunities. Open Access Articles. Retrieved from https://escholarship.umassmed.edu/oapubs/3255 Creative Commons License This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. Clinical research Tobacco use disorder and treatment: new challenges and opportunities Douglas Ziedonis, MD, MPH; Smita Das, MD, PhD, MPH; Celine Larkin, PhD Introduction obacco use is the cause of over 5 million deaths perT year globally,1 over twice as many deaths due to al- cohol and illicit drugs combined. If current consump- tion rates continue, tobacco is projected to kill 1 billion people this century, with the majority of deaths occur- ring in low- and middle-income countries,2 although there is good evidence for the effectiveness both of pol- Tobacco use remains a global problem, and options for consumers have increased with the development and mar- keting of e-cigarettes and other new nicotine and tobacco products, such as “heat-not-burn” tobacco and dissolv- able tobacco.
    [Show full text]
  • Rotational Health Warnings for Cigarettes File No
    UNITED STATES OF AMERICA FEDERAL TRADE COMMISSION WASHINGTON, D C. 20580 Division of Advertising Practices June 5,2001 MEMORANDUM TO: Public Records Office of the Secretary FROM: Sallie Schools Division of Advertising Practices SUBJECT: Rotational Health Warnings for Cigarettes File No. Please place the attached documents on the public record in the above-captioned matter. December 25,2000 letter from Mohammed Babul, Bengal Tobacco to C. Lee Peeler. 2. January 3,2001 letter C. Lee Peeler to Mohammed Babul, Bengal Tobacco. 3. October 11,2000 letter fiom Clara Weaver, Liggett Group to C. Lee Peeler. 4. January 4,2001 letter fkom C. Lee Peeler to Clara Weaver, Liggett Group. 5. January 5,2001 letter from Everett Gee, Esq. on behalf of Brands to C. Lee Peeler. 6. January 8,2001 letter fkom C. Lee Peeler to Everett Gee, Esq. on behalf of Brands. 7. January 16,2001 letter from Andrew Parish, Esq. on behalf of Tobacco Center to C. Lee Peeler. 8. January 17,2001 letter from C. Lee Peeler to Andrew Parish, Esq. on behalf of Tobacco Center. 9. January 16,2001 letter fkom Neal Beaton, Esq. on behalf of Japan Tobacco to C. Lee Peeler. 1 Records June 5,2001 Page 2 10. January 19,2001 letter fiom C. Lee Peeler to Neal Beaton, Esq. on behalf of Japan Tobacco. 11. January 10,2001 letter Thomas O’Connell, Sun Tobacco to C. Lee Peeler. 12. January 22,2001 letter from C. Lee Peeler to Thomas O’Connell, Sun Tobacco. 13. January 18,2001 letter fiom Kris Hewitt, Tobacco to C.
    [Show full text]
  • Current Status of the Reduced Propensity Ignition Cigarette Program in Hawaii
    Hawaii State Fire Council Current Status of the Reduced Propensity Ignition Cigarette Program in Hawaii Submitted to The Twenty-Eighth State Legislature Regular Session June 2015 2014 Reduced Ignition Propensity Cigarette Report to the Hawaii State Legislature Table of Contents Executive Summary .…………………………………………………………………….... 4 Purpose ..………………………………………………………………………....................4 Mission of the State Fire Council………………………………………………………......4 Smoking-Material Fire Facts……………………………………………………….............5 Reduced Ignition Propensity Cigarettes (RIPC) Defined……………………………......6 RIPC Regulatory History…………………………………………………………………….7 RIPC Review for Hawaii…………………………………………………………………….9 RIPC Accomplishments in Hawaii (January 1 to June 30, 2014)……………………..10 RIPC Future Considerations……………………………………………………………....14 Conclusion………………………………………………………………………….............15 Bibliography…………………………………………………………………………………17 Appendices Appendix A: All Cigarette Fires (State of Hawaii) with Property and Contents Loss Related to Cigarettes 2003 to 2013………………………………………………………18 Appendix B: Building Fires Caused by Cigarettes (State of Hawaii) with Property and Contents Loss 2003 to 2013………………………………………………………………19 Appendix C: Cigarette Related Building Fires 2003 to 2013…………………………..20 Appendix D: Injuries/Fatalities Due To Cigarette Fire 2003 to 2013 ………………....21 Appendix E: HRS 132C……………………………………………………………...........22 Appendix F: Estimated RIPC Budget 2014-2016………………………………...........32 Appendix G: List of RIPC Brands Being Sold in Hawaii………………………………..33 2 2014
    [Show full text]
  • Appendix 1. Categorization of Cigarette Brands As Either Premium Or Discount
    Appendix 1. Categorization of Cigarette Brands as either Premium or Discount Category Name of Cigarette Brand Premium Accord, American Spirit, Barclay, Belair, Benson & Hedges, Camel, Capri, Carlton, Chesterfield, Davidoff, Du Maurier, Dunhill, Dunhill International, Eve, Kent, Kool, L&M, Lark, Lucky Strike, Marlboro, Max, Merit, Mild Seven, More, Nat Sherman, Newport, Now, Parliament, Players, Quest, Rothman’s, Salem, Sampoerna, Saratoga, Tareyton, True, Vantage, Virginia Slims, Winston, Raleigh, Business Club Full Flavor, Ronhill, Dreams Discount 24/7, 305, 1839, A1, Ace, Allstar, Allway Save, Alpine, American, American Diamond, American Hero, American Liberty, Arrow, Austin, Axis, Baileys, Bargain Buy, Baron, Basic, Beacon, Berkeley, Best Value, Black Hawk, Bonus Value, Boston, Bracar, Brand X, Brave, Brentwood, Bridgeport, Bronco, Bronson, Bucks, Buffalo, BV, Calon, Cambridge, Campton, Cannon, Cardinal, Carnival, Cavalier, Champion, Charter, Checkers, Cherokee, Cheyenne, Cimarron, Circle Z, Class A, Classic, Cobra, Complete, Corona, Courier, CT, Decade, Desert Gold, Desert Sun, Discount, Doral, Double Diamond, DTC, Durant, Eagle, Echo, Edgefield, Epic, Esquire, Euro, Exact, Exeter, First Choice, First Class, Focus, Fortuna, Galaxy Pro, Gauloises, Generals, Generic/Private Label, Geronimo, Gold Coast, Gold Crest, Golden Bay, Golden, Golden Beach, Golden Palace, GP, GPC, Grand, Grand Prix, G Smoke, GT Ones, Hava Club, HB, Heron, Highway, Hi-Val, Jacks, Jade, Kentucky Best, King Mountain, Kingsley, Kingston, Kingsport, Knife, Knights,
    [Show full text]
  • Arrest Report - 2019
    Arrest Report - 2019 Arrest:19TEW-41-A-AR Date:1/1/2019 Last Name: CORREA First Name:YANELA Age: 18 Address:156 CYPRESS ST City:MANCHESTER State: NH Offense COCAINE, TRAFFICKING IN, 36 GRAMS OR MORE, LESS THAN 100 GRAMS Arrest:19TEW-41-AR Date:1/1/2019 Last Name: MENDOZA First Name:ELVIN Age: 22 Address:9 BYRON AVE City:LAWRENCE State: MA Offense COCAINE, TRAFFICKING IN, 36 GRAMS OR MORE, LESS THAN 100 GRAMS WARRANT - 1818CR003461 - TRAFFICKING IN 100 GRMS HEROIN WARRANT-DOCKET#1818CR006396 - OP MV W/ REVOKED LICENSE Arrest:19TEW-294-AR Date:1/2/2019 Last Name: KING First Name:TAMMY Age: 37 Address:181 LOUDON RD City:CONCORD State: NH Offense ASSAULT W/DANGEROUS WEAPON/ TO WIT CLEANING BOTTLE VANDALIZE PROPERTY c266 §126A DISGUISE TO OBSTRUCT JUSTICE WARRANT -LARCENY OVER 1200.00 266/30/B WARRANT - LARCENY OVER 1200.00 - 266/30/A WARRANT - LARCENY OVER 1200.00 BY SINGLE SCHEME - 266/30/B WARRANT - SHOPLIFTING $250+ BY ASPORTATION - 266/30A/S THREAT TO COMMIT CRIME - ASSAULT & BATTERY Arrest:19TEW-337-AR Date:1/3/2019 Last Name: PUNTONI First Name:CORY Age: 27 Address:10 LOCKE ST City:HAVERHILL State: MA Offense WARRANT- DOCKET#1838CR002437-ORDINANCE VIOLATION Arrest:19TEW-470-AR Date:1/3/2019 Last Name: GUTHRIE First Name:CHRISTOPHER Age: 31 Address:108 CHAPEL ST City:LOWELL State: MA Offense Page 1 of 10 WARRANT DOCKET #1711CR001501 C275 S2 THREATENING TO COMMIT CRIME WARRANT DOCKET #1811CR004055 90-23 LICENSE SUSPENDED Arrest:19TEW-485-AR Date:1/3/2019 Last Name: DYESS First Name:CHRISTOPHER Age: 35 Address:133 SHAWSHEEN ST City:TEWKSBURY
    [Show full text]
  • Directory for Cigarettes and Roll-Your-Own Tobacco
    DEPARTMENT OF THE ATTORNEY GENERAL STATE OF HAWAI‘I DIRECTORY FOR CIGARETTES AND ROLL-YOUR-OWN TOBACCO of (Available at: http://ag.hawaii.gov/cjd/tobacco-enforcement-unit/) Certified Tobacco Product Manufacturers Their Brands and Brand Families DEPARTMENT OF THE ATTORNEY GENERAL TOBACCO ENFORCEMENT UNIT 425 QUEEN STREET HONOLULU, HAWAI‘I 96813 (808) 586-1203 INDEX I. Directory: Cigarettes and Roll-Your-Own Tobacco Page 1. INTRODUCTION 3 2. DEFINITIONS 3 3. NOTICES 5 II. Update Summary For June 1, 2018 Posting * III. Alphabetical Brand List IV. Compliant Participating Manufacturers List V. Compliant Non-Participating Manufacturers List Posted: June 1, 2018 (updated most recent 9/5/2018) 2 1. INTRODUCTION Pursuant to Haw. Rev. Stat. §245-22.5(a), beginning December 1, 2003, it shall be unlawful for an entity (1) to affix a stamp to a package or other container of cigarettes belonging to a tobacco product manufacturer or brand family not included in this directory, or (2) to import, sell, offer, keep, store, acquire, transport, distribute, receive, or possess for sale or distribution cigarettes1 belonging to a tobacco product manufacturer or brand family not included in this directory. Pursuant to §245-22.5(b), any entity that knowingly violates subsection (a) shall be guilty of a class C felony. Pursuant to Haw. Rev. Stat. §§245-40 and 245-41, any cigarettes unlawfully possessed, kept, stored, acquired, transported, or sold in violation of Haw. Rev. Stat. §245-22.5 may be ordered forfeited pursuant to Haw. Rev. Stat., Chapter 712A. In addition, the attorney general may apply for a temporary or permanent injunction restraining any person from violating or continuing to violate Haw.
    [Show full text]
  • Tobacco Directory Deletions by Manufacturer
    Cigarettes and Tobacco Products Removed From The California Tobacco Directory by Manufacturer Brand Manufacturer Date Comments Removed Catmandu Alternative Brands, Inc. 2/3/2006 Savannah Anderson Tobacco Company, LLC 11/18/2005 Desperado - RYO Bailey Tobacco Corporation 5/4/2007 Peace - RYO Bailey Tobacco Corporation 5/4/2007 Revenge - RYO Bailey Tobacco Corporation 5/4/2007 The Brave Bekenton, S.A. 6/2/2006 Barclay Brown & Williamson * Became RJR July 5/2/2008 2004 Belair Brown & Williamson * Became RJR July 5/2/2008 2004 Private Stock Brown & Williamson * Became RJR July 5/2/2008 2004 Raleigh Brown & Williamson * Became RJR July 5/6/2005 2004 Viceroy Brown & Williamson * Became RJR July 5/3/2010 2004 Coronas Canary Islands Cigar Co. 5/5/2006 Palace Canary Islands Cigar Co. 5/5/2006 Record Canary Islands Cigar Co. 5/5/2006 VL Canary Islands Cigar Co. 5/5/2006 Freemont Caribbean-American Tobacco Corp. 5/2/2008 Kingsboro Carolina Tobacco Company 5/3/2010 Roger Carolina Tobacco Company 5/3/2010 Aura Cheyenne International, LLC 1/5/2018 Cheyenne Cheyenne International, LLC 1/5/2018 Cheyenne - RYO Cheyenne International, LLC 1/5/2018 Decade Cheyenne International, LLC 1/5/2018 Bridgeton CLP, Inc. 5/4/2007 DT Tobacco - RYO CLP, Inc. 7/13/2007 Railroad - RYO CLP, Inc. 5/30/2008 Smokers Palace - RYO CLP, Inc. 7/13/2007 Smokers Select - RYO CLP, Inc. 5/30/2008 Southern Harvest - RYO CLP, Inc. 7/13/2007 Davidoff Commonwealth Brands, Inc. 7/19/2016 Malibu Commonwealth Brands, Inc. 5/31/2017 McClintock - RYO Commonwealth Brands, Inc.
    [Show full text]
  • “Mevius Mode 6 100'S” and “Mevius Mode 3 100'S”
    FOR IMMEDIATE RELEASE Tokyo, April 21, 2015 Black Mevius Richer flavor through a lavish blend. Reduced smoke smell. “Mevius Mode 6 100’s” and “Mevius Mode 3 100’s” To be rolled out across Japan in early June, 2015 Japan Tobacco Inc. (JT) (TSE: 2914) has announced two new additions to the Mevius Mode series, which incorporates LSS* technology. “Mevius Mode 6 100’s” and “Mevius Mode 3 100’s” are to be rolled out across Japan in early June. A richer flavor through a lavish blend, and reduced smoke smell as well “Mevius Mode 6 100’s” and “Mevius Mode 3 100’s” The Mevius Mode Series products, which retain the smooth and clear flavor of Mevius and incorporate JT’s LSS technology, have been very well received by consumers. Now JT is launching “Mevius Mode 6 100’s” and “Mevius Mode 3 100’s”, in addition to the popular rich flavor “Mevius Mode One 100’s” launched in 2011. Thanks to a lavish blend, consumers can enjoy a richer flavor than that of the regular Mevius series. Employing the FSK size (approx.100 mm) instead of the FK one (approx. 85 mm) provides not just longer smoking experience, but also more satisfaction with each cigarette. In addition, the new products also incorporate LSS technology. The packages will feature the streamline motif of Mevius with vibrant blue and orange gradations on a black background. Furthermore, the sense of premium stylishness of the packages is enhanced by creating a special texture, which is achieved by ingenious use of gloss colors.
    [Show full text]
  • Challenges to Tackling Antimicrobial Resistance
    Challenges to Tackling Antimicrobial Resistance Antimicrobial resistance (AMR) is a biological mechanism whereby a microorganism evolves over time to develop the ability to become resistant to antimicrobial therapies such as antibiotics. The drivers of and poten- tial solutions to AMR are complex, often spanning multiple sectors. The internationally recognized response to AMR advocates for a ‘One Health’ approach, which requires policies to be developed and implemented across human, animal, and environmental health. To date, misaligned economic incentives have slowed the development of novel antimicrobials and lim- ited efforts to reduce antimicrobial usage. However, the research which underpins the variety of policy options to tackle AMR is rapidly evolving across multiple disciplines such as human medicine, veterinary medicine, agricultural sciences, epidemiology, economics, sociology and psychology. By bringing together in one place the latest evidence and analysing the different facets of the complex problem of tackling AMR, this book offers an accessible summary for policy-makers, academics and students on the big questions around AMR policy. This title is also available as Open Access on Cambridge Core. Michael anderson is a Research Officer in Health Policy at the Department of Health Policy, London School of Economics and Political Science, and a Medical Doctor undertaking General Practice specialty training. Michele cecchini is a Senior Health Economist, Health Division, in the Directorate for Employment, Labour and Social Affairs, Organisation for Economic Co-operation and Development. elias Mossialos is Brian Abel-Smith Professor of Health Policy, Head of the Department of Health Policy at the London School of Economics and Political Science, and Co-Director of the European Observatory on Health Systems.
    [Show full text]
  • A TOBACCO-FREE SLOVENIA with the Help of Ngos
    A TOBACCO-FREE SLOVENIA with the help of NGOs 1 Slovenian Coalition for Public Health, Environment and Tobacco Control-SCTC October 2019 A TOBACCO-FREE SLOVENIA with the help of NGOs Slovenian Coalition For Public Health, Environment and Tobacco Control October 2019 TABLE OF CONTENTS Introduction: And yet we’re smoking less ................................................................................................................... 3 A few facts Smoking and its consequences in Slovenia .................................................................................................................. 5 Toxins in cigarettes ........................................................................................................................................................ 6 Electronic cigarettes ...................................................................................................................................................... 7 Herbal cigarettes ........................................................................................................................................................... 8 Tobacco industry revenues ........................................................................................................................................... 9 WHO Framework Convention ..................................................................................................................................... 11 Slovenian legislation...................................................................................................................................................
    [Show full text]